hit counter
USA Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Endogena Therapeutics Receives US FDA Fast Track Designation for EA-2353 for the Treatment of Retinitis Pigmentosa

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Endogena Therapeutics

Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Singular Genomics Systems, Inc.

Viridian Appoints Scott Myers as President and Chief Executive Officer

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Viridian Therapeutics, Inc.

Hillstream BioPharma to Host Virtual R&D Day to Showcase its Emerging Immuno-oncology Pipeline Targeting Drug-Resistant Cancers

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Hillstream BioPharma Inc.

Tonix Pharmaceuticals Initiates Enrollment in Phase 2 ‘PREVENTION’ Study of Potentiated Intranasal Oxytocin (TNX-1900) for the Prevention of Migraine Headaches in Chronic Migraineurs

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Tonix Pharmaceuticals Holding Corp.

Singular Genomics Launches Max Read™ Kits for Single Cell Sequencing on the G4 at AGBT

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Singular Genomics Systems, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  BioCryst Pharmaceuticals, Inc.

HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  HeartSciences Inc.

Inozyme Pharma to Host Virtual Investor and Analyst Event on Feb. 16, 2023

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Inozyme Pharma

Arbutus to Participate in Three Upcoming Investor Conferences

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Arbutus Biopharma Corporation

Clearside Biomedical Announces Leadership Team Update

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Clearside Biomedical, Inc.

Context Therapeutics Highlights Clinical Responses from the Phase 2 OATH Clinical Trial Evaluating ONA-XR for the Treatment of Endometrial Cancer

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Context Therapeutics Inc.

Sensei Biotherapeutics Signs Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to Expand Development Plan for SNS-101, a Conditionally Active VISTA-blocking Antibody

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Sensei Biotherapeutics, Inc.

Lyra Therapeutics Announces Completion of Enrollment in the BEACON Phase 2 Clinical Trial of LYR-220 in Post-Surgical Chronic Rhinosinusitis Patients

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Lyra Therapeutics, Inc.

Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Atreca, Inc.

aTyr Pharma Announces Achievement of Development Milestone by Partner Kyorin Pharmaceutical, Co., Ltd.

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  aTyr Pharma Inc. | Lifecare AS | Pharmsynthez

Oncotelic Announces Initiation of Clinical Study in Non-Small Lung Cell Cancer

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Oncotelic, Inc. | Oncotelic Therapeutics

Vincerx Pharma to Participate at the SVB Securities Global Biopharma Conference

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Vincerx Pharma, Inc.

ORYZON to Give Updates on Corporate Progress in February-March

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Oryzon Genomics, S.A. | Oryzon Genomics, S.A.

Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

Read more ››
By: GlobenewsWire - 06 Feb 2023
Related companies:  Opiant Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • February 2023
    • Biotechgate Digital Partnering February 2023
    • Dusseldorf: 7th ECP - The first industry speed dating event
  • March 2023
    • Zurich: 16th​ Annual European Life Sciences CEO Forum
See Events »
Add an Event »

Latest company news

MediciNova Announces Health Canada Grants Authorization to Commence Multi-arm Phase 2/3 Clinical Trial to Evaluate MN-166 (ibudilast) in Long COVID
09 Feb 2023 (GlobenewsWire)

EYLEA® (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
09 Feb 2023 (GlobenewsWire)

Carrier screening market size to grow by USD 2.36 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
09 Feb 2023 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com